SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4749 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions:

How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Prevalence and Risk Factors of Sleep Disordered Breathing in a Heart Failure Program

NCT00679822

Sleep Apnea Heart Failure

COMPLETED

Sleep-related Breathing Disorders in Cardiological Outpatients

NCT02693925

Sleep Apnea Syndromes

COMPLETED

The Epidemiology of Sleep Disordered Breathing in Patients With Congestive Heart Failure

NCT05332223

Chronic Heart Failure Sleep Disorder

COMPLETED

Validation of the Peripheral Arterial Tone to Detect Sleep-disordered Breathing in Patients With Chronic Heart Failure

NCT02760680

Sleep-Disordered Breathing

COMPLETED NA

The Prevalence of Sleep Disordered Breathing in Hospitalized Patients With Acutely Decompensated Heart Failure Syndrome

NCT00701519

Sleep Apnea Congestive Heart Failure Heart Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure (HF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heart Failure patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnose chronic heart failure, at least 3 months prior to diagnosis
* Age 18 years
* Signed informed consent

Exclusion Criteria

* Existing Positive Airway Pressure (PAP) therapy or long-term oxygen therapy
* Lack of capacity to consent
* minors
* persons who are housed on judicial or administrative order in an institution
* pregnant and lactating women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No